This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Cefazoline for injection

Starting date:
February 11, 2015
Posting date:
February 13, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-43713

Recalled Products

Reason

The recalled lots may contain foreign particles.

Depth of distribution

Retailers

Affected products

Cefazoline for injection

DIN, NPN, DIN-HIM
DIN 02297205
Dosage form

Powder For Solution

Strength

Cefazolin (Cefazolin Sodium) 1 g/vial

Lot or serial number
  • 117E005
  • 117E006
Companies
Recalling Firm
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA

Date modified: